KEPATUHAN PENGGUNAAN OBAT DAN KUALITAS HIDUP PASIEN HEMODIALISA DI RS PKU MUHAMMADIYAH YOGYAKARTA PERIODE MARET 2015

Endah Karuniawati, Woro Supadmi

Abstract


The adherence holds an important role that can affect the success rate of the therapy and increase the life quality of the patients. Quality of life is an ability to reflect the health in the term of physically, psychology, and socially and the satisfaction of the patients functional and control level. Research aims to understand relations compliance treatment with the quality of life can be measured by MMAS and WHOQOL questioners. The research applied descriptive, non experimental and cross-sectional methods. The aim of the research was to find out the relationship between the medication adherence and the life quality of the hemodialysis patients. The medication adherence data was gathered by MMAS (Morisky Medication Adherence Scale) and the life quality was gathered by WHOQOL (World Health Organization Quality of Life) of hemodialysis patients at PKU Muhammadiyah Yogyakarta Hospital. The research results showed that from 101 respondents the medication adherence in the level of high 58,42 %, level moderate 8 , 91 % and low 32 , 67 %.) .The quality of life of patients of the domain physical, mental, social and environmental at a high rate and low. Relations adherence the use of a drug with the quality of life of significant (p< 0,005) in all the domain. Compliance the use of drugs associated with the quality of life of hemodialysis patients at PKU Muhammadiyah Yogyakarta Hospital.


Keywords


adherence; life quality; MMAS; WHOQOL

Full Text:

PDF

References


Anonim, 2014. Center for Disease Control and Prevention-National Center for Health Statixtics: Morbidity Adults with Diagnose Kidney Disease, http:// www.cdc.gov.nchs.htm

Baradero, M, Dayrit, M.W., Siswandi, Y., 2008. Seri Asuhan Keperawatan Pada Klien Gangguan Ginjal. Jakarta, EGC, 148.

Brunner, F.P., & Suddarth, N.H., 2001. End-Stage Renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. Nephrol Dial Transplant, 9, 1371-1376.

Carol, W, 2013. Common Medication for People receiving Haemodialysis. Birmingham. Renal Unit Queen Elizabeth Hospital Birmingham.

Departemen Kesehatan RI, 2013. Laporan Riskesdas 2013. http://www.depkes.go.id/resources/download/general/Hasil%20Riskesdas%202013.pdf., diakses pada tanggal 30 April 2015.

Garcia-Llana, Remor, E., Selgas, R. 2013. Adherence to treatment, emotional state and quality of life in patients with end-stage renal disease undergoing dialysis. Psicothema, 25(1), 79-86.

Hussar, D.A., 1995. Drug Interaction, Remington : The Science and Practise of Pharmacy, vol 11, 19th Ed. Pennsylvania, Mack Publishing Companya Easton, 1822-1836.

Ibrahim S., Hossam M., Belal D., 2015. Study of Non-Compliance among Chronic Hemodialysis Patient Its Impact on Patients Outcomes, Saudi J Kidney Dis Transpl., 26(2), 243-249.

Indonesian Renal Registry, 2012. Data Penderita Gagal Ginjal Kronik yang Menjalani Hemodialisis. Jawa Barat.

National Kidney Foudation, 2015. Kidney Disease Outcome Quality Initiative, Cinical Practice Guidline for Hemodialysis Adequacy. http://www. Kidney.org/professional/KDOQI/ Guidline_ckd/p4.htm

Zyoud, S.H., Daraghmeh, D.N., Mezyed D.O. et al , 2016, Factors affecting quality of life in patients on haemodialysis: a cross-sectional study from Palestine, BMC Nephrology, 17,44.




DOI: https://doi.org/10.24071/jpsc.00190

Article Metrics

Abstract view : 3645 times
PDF view: 2893 times

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Pharmaceutical Sciences and Community

 

 

 

 

 

 

 

  

Jurnal Farmasi Sains dan Komunitas (Journal of Pharmaceutical Sciences and Community)

Published by Faculty of Pharmacy, Universitas Sanata Dharma Yogyakarta

Creative Commons Licence
This work is licensed under a Creative Commons Attribution 4.0 International License.

JPSC Stats